Literature DB >> 7675242

No evidence for association of familial Parkinson's disease with CAG repeat expansion.

R Carĕro-Valenzuela1, K Lindblad, H Payami, W Johnson, M Schalling, E S Stenroos, S Shattuc, J Nutt, A Brice, M Litt.   

Abstract

In some kindreds, familial Parkinson's disease (PD) exhibits genetic anticipation. Thus, we postulated that familial PD in certain kindreds may be associated with a CAG repeat expansion. However, using the repeat expansion detection method, we found no significant increase in the frequency of CAG repeat expansion among 46 unrelated PD probands compared with controls. Nor did we find evidence for CAG repeat expansion between generations in 11 different PD families that exhibit anticipation in age at onset.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675242     DOI: 10.1212/wnl.45.9.1760

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

2.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset.

Authors:  P J Morrison; R B Godwin-Austen; J A Raeburn
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

4.  Genes and parkinsonism.

Authors:  N Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

5.  Uncloned expanded CAG/CTG repeat sequences in autosomal dominant cerebellar ataxia (ADCA) detected by the repeat expansion detection (RED) method.

Authors:  M A Pujana; V Volpini; M Gratacós; J Corral; I Banchs; A Sánchez; D Genís; C Cervera; X Estivill
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.